APcK110
Product Specifications
CAS Number
1001083-74-4
Target
Others, c-Kit
Related Pathways
Tyrosine Kinase/Adaptors, Others
Bioactivity
APcK110 is a novel Kit inhibitor . APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner . APcK110 is a more potent inhibitor of OCI/AML3 proliferation than the clinically used Kit inhibitors imatinib and dasatinib and at least as potent as cytarabine. APcK110 inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt in a dose-dependent fashion, showing activity of APcK110 on Kit and its downstream signaling pathways . APcK110 may have potent application in AML.
Smiles
FC1=CC=C(C=2C=3C(=NC(=CC3)C4=CC(OC)=CC(OC)=C4)NN2)C=C1
Molecular Formula
C20H16FN3O2
Molecular Weight
349.36
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Monoclonal Villin 1 Antibody (VIL1/2310R) [Alexa Fluor 594]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
NBP3-08929AF594 100 µL
Rabbit Monoclonal Villin 1 Antibody (VIL1/2310R) [Alexa Fluor 594]
Sign In for Pricing
View Details 
FAB3832E 0.1 mL
Mouse Monoclonal CD14 Antibody (134620) [DyLight 405]
Sign In for Pricing
View Details MBS1481655-01 0.02 mg (E-Coli)
Recombinant Xenopus laevis Fumarylacetoacetate hydrolase domain-containing protein 2 (fahd2)
Sign In for Pricing
View Details MBS1481655-02 0.02 mg (Yeast)
Recombinant Xenopus laevis Fumarylacetoacetate hydrolase domain-containing protein 2 (fahd2)
Sign In for Pricing
View Details MBS1481655-03 0.1 mg (E-Coli)
Recombinant Xenopus laevis Fumarylacetoacetate hydrolase domain-containing protein 2 (fahd2)
Sign In for Pricing
View Details